BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28132997)

  • 21. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.
    Coenegrachts K; Orlent H; ter Beek L; Haspeslagh M; Bipat S; Stoker J; Rigauts H
    J Magn Reson Imaging; 2008 Jan; 27(1):117-24. PubMed ID: 18050350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging.
    Wáng YX; Idée JM
    Quant Imaging Med Surg; 2017 Feb; 7(1):88-122. PubMed ID: 28275562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution and pharmacokinetic studies of SPION using particle electron paramagnetic resonance, MRI and ICP-MS.
    Gobbo OL; Wetterling F; Vaes P; Teughels S; Markos F; Edge D; Shortt CM; Crosbie-Staunton K; Radomski MW; Volkov Y; Prina-Mello A
    Nanomedicine (Lond); 2015; 10(11):1751-60. PubMed ID: 26080697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A preparation technique for quantitative investigation of SPIO-containing solutions and SPIO-labelled cells by MRI].
    Pintaske J; Helms G; Bantleon R; Kehlbach R; Wiskirchen J; Claussen CD; Schick F
    Biomed Tech (Berl); 2005 Jun; 50(6):174-80. PubMed ID: 16003918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging.
    Yang F; Li Y; Chen Z; Zhang Y; Wu J; Gu N
    Biomaterials; 2009 Aug; 30(23-24):3882-90. PubMed ID: 19395082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis of Gal-BSA-SPIO and magnetic resonance imaging of ASG receptors in rabbits bearing liver VX2 tumor and human liver].
    Jia FG; Zhang XD; Xu YK; Meng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):191-4. PubMed ID: 19246275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media].
    Bartolotta TV; Midiri M; Galia M; Carcione A; De Maria M; Lagalla R
    Radiol Med; 2001 Apr; 101(4):219-29. PubMed ID: 11398050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of administration of SPIO prior to RF ablation for evaluation of the therapeutic effect: an experimental study using miniature pigs.
    Kakite S; Fujii S; Nakamatsu S; Kanasaki Y; Yamashita E; Matsusue E; Ouchi Y; Kaminou T; Tokunaga S; Koda M; Ogawa T
    Eur J Radiol; 2011 May; 78(2):282-6. PubMed ID: 21296516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
    Prashant C; Dipak M; Yang CT; Chuang KH; Jun D; Feng SS
    Biomaterials; 2010 Jul; 31(21):5588-97. PubMed ID: 20434210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions.
    Macarini L; Marini S; Milillo P; Vinci R; Ettorre GC
    Radiol Med; 2006 Dec; 111(8):1087-102. PubMed ID: 17171525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEG-copolymer-coated iron oxide nanoparticles that avoid the reticuloendothelial system and act as kidney MRI contrast agents.
    Gómez-Vallejo V; Puigivila M; Plaza-García S; Szczupak B; Piñol R; Murillo JL; Sorribas V; Lou G; Veintemillas S; Ramos-Cabrer P; Llop J; Millán A
    Nanoscale; 2018 Aug; 10(29):14153-14164. PubMed ID: 29999506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From cartoon to real time MRI: in vivo monitoring of phagocyte migration in mouse brain.
    Mori Y; Chen T; Fujisawa T; Kobashi S; Ohno K; Yoshida S; Tago Y; Komai Y; Hata Y; Yoshioka Y
    Sci Rep; 2014 Nov; 4():6997. PubMed ID: 25385430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
    von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
    Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vivo MR imaging tracking of supermagnetic iron-oxide nanoparticle-labeled bone marrow mesenchymal stem cells injected into intra-articular space of knee joints: experiment with rabbit].
    Jin XH; Yang L; Duan XJ; Xie B; Li Z; Tan HB
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3213-8. PubMed ID: 18399117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy.
    Hauger O; Frost EE; van Heeswijk R; Deminière C; Xue R; Delmas Y; Combe C; Moonen CT; Grenier N; Bulte JW
    Radiology; 2006 Jan; 238(1):200-10. PubMed ID: 16373768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive analysis of transfection-assisted delivery of iron oxide nanoparticles to dendritic cells.
    Toki S; Omary RA; Wilson K; Gore JC; Peebles RS; Pham W
    Nanomedicine; 2013 Nov; 9(8):1235-44. PubMed ID: 23747738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo long-term magnetic resonance imaging activity of ferritin-based magnetic nanoparticles versus a standard contrast agent.
    Valero E; Fiorini S; Tambalo S; Busquier H; Callejas-Fernández J; Marzola P; Gálvez N; Domínguez-Vera JM
    J Med Chem; 2014 Jul; 57(13):5686-92. PubMed ID: 24901375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
    Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
    Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The behavior after intravenous injection in mice of multiwalled carbon nanotube / Fe3O4 hybrid MRI contrast agents.
    Wu H; Liu G; Zhuang Y; Wu D; Zhang H; Yang H; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(21):4867-76. PubMed ID: 21459436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.